scholarly journals -429T/C and -374T/A Polymorphisms of RAGE Gene Promoter Are Not Associated With Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes

Diabetes Care ◽  
2003 ◽  
Vol 26 (9) ◽  
pp. 2696-2697 ◽  
Author(s):  
X. JiXiong ◽  
X. BiLin ◽  
Y. MingGong ◽  
L. ShuQin
Diabetologia ◽  
2015 ◽  
Vol 58 (6) ◽  
pp. 1231-1238 ◽  
Author(s):  
Danfeng Peng ◽  
Jie Wang ◽  
Rong Zhang ◽  
Feng Jiang ◽  
Shanshan Tang ◽  
...  

2020 ◽  
Author(s):  
haiyan cheng ◽  
lan xu ◽  
ruifang bu ◽  
cheng jiang ◽  
lijun yao ◽  
...  

Abstract Background: Progranulin (PGRN), a novel pro-inflammatory adipokine, was reported to be related to the development and progression of diabetic retinopathy(DR). However, recently PGRN was established as a renal function-dependent protein, but no data regarding PGRN and DR excluded the influence of decreased renal elimination. This study aimed to investigate the correlation between serum PGRN and DR excluding the effect of deteriorating renal function.Methods: 338 subjects with estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73m2 were divided into four groups of normal controls (NC)(n=76), simple diabetes mellitus (SDM)(n=195) , nonproliferative diabetic retinopathy (NPDR)(n=41), and proliferative diabetic retinopathy (PDR)(n=26). Serum PGRN was quantified by enzyme-linked immunosorbent assay, and further analyses of serum PGRN in different groups were conducted. Results: There was no significant difference of serum PGRN between NC, SDM, NPDR, and PDR groups (P>0.05). Serum PGRN in all subjects negatively and significantly correlated with eGFR (r=-0.144, P<0.05), triglycerides and glucose (TyG) index (r=-0.127, P<0.05), and triglyceride (TG) (r=-0.132, P<0.05), while positively and significantly correlated with low-density lipoprotein cholesterol (LDL-C) (r=0.140, P<0.05). Multivariate stepwise regression analysis indicated only LDL-C (β=1.030, P<0.05) was independently associated with serum PGRN. Conclusions: We demonstrated that serum PGRN levels did not correlate with severity of DR in Chinese patients with type 2 diabetes and eGFR ≥ 60ml/min/1.73m2, but positively and independently correlated with LDL-C.


2018 ◽  
Vol 38 (5) ◽  
Author(s):  
Jia-Ying Li ◽  
Xian-Xian Chen ◽  
Xiao-Hua Lu ◽  
Chuang-Biao Zhang ◽  
Qi-Ping Shi ◽  
...  

The retinol-binding protein 4 (RBP4) has been postulated to play a role in glucose homeostasis, insulin resistance, and diabetes mellitus in human and animal studies. The aim of the present study was to evaluate the role of RBP4 in Chinese patients with type 2 diabetes mellitus with and without diabetic retinopathy (DR). Plasma RBP4 concentrations were tested in 287 patients with type 2 diabetes. At baseline, demographic and clinical information including presence of DR and vision-threatening DR (VTDR) was collected. The relationship between RBP4 and DR (VTDR) was investigated using logistic regression. Patients with DR or VTDR had significantly higher plasma levels of RBP4 on admission (P<0.0001). Receiver operating characteristics (ROCs) to predict DR and VDTR demonstrated areas under the curve for RBP4 of 0.79 (95% confidence interval (CI): 0.73–0.85) and 0.90 (95% CI: 0.85–0.94), respectively, which were superior to other factors. For each 1 μg/ml increase in plasma level of RBP4, the unadjusted and adjusted risk of DR would be increased by 8% (with the odds ratio (OR) of 1.08 (95% CI: 1.05–1.13), P<0.001) and 5% (1.05 (1.02–1.11), P=0.001), respectively. It was 12% (with the OR of 1.12 (95% CI: 1.07–1.18), P<0.001) and 9% (1.09 (1.05–1.15), P<0.001) for VTDR. The present study shows that elevated plasma levels of RBP4 were associated with DR and VDTR in Chinese patients with type 2 diabetes, suggesting a possible role of RBP4 in the pathogenesis of DR complications. Lowering RBP4 could be a new strategy for treating type 2 diabetes with DR.


Sign in / Sign up

Export Citation Format

Share Document